Chirantan Chatterjee

Sitert av

	Alle	Siden 2020
Sitater	1209	884
h-indeks	16	16
i10-indeks	27	25

260

130

195

200920102011201220132014201520162017201820192020202120222023202420254 4 7 10 13 22 27 50 39 61 73 90 129 175 198 244 43

Offentlig tilgang

Vis alle

5 artikler

0 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Matthew J. HigginsEmma Eccles Jones Chair & Professor of Entrepreneurship & Strategy, David Eccles School of BusinessVerifisert e-postadresse på eccles.utah.edu
Lee BranstetterProfessor of Public Policy and Economics, Carnegie Mellon UniversityVerifisert e-postadresse på cmu.edu
Arzi AdbiAssociate Professor, National University of Singapore Business SchoolVerifisert e-postadresse på nus.edu.sg
Prof. Viswanath PingaliEconomics area, Indian Institute of ManagementVerifisert e-postadresse på iimahd.ernet.in
Ashish AroraFuqua School of BusinessVerifisert e-postadresse på duke.edu
Zoe KiniasIvey Business School, Western UniversityVerifisert e-postadresse på ivey.ca
Matej DrevGeorgia Institute of TechnologyVerifisert e-postadresse på pubpolicy.gatech.edu
D. Daniel SokolUSC Gould School of Law and USC Marshall School of BusinessVerifisert e-postadresse på usc.edu
Jasjit SinghProfessor of Strategy and Paul Dubrule Chair in Sustainable Development, INSEADVerifisert e-postadresse på insead.edu
Enrico PenningsProfessor of Applied Industrial Organization at Erasmus School of EconomicsVerifisert e-postadresse på ese.eur.nl
Neeraj SoodSol Price School of Public Policy, Schaeffer Center, USCVerifisert e-postadresse på usc.edu
Kamal SaggiVanderbilt UniversityVerifisert e-postadresse på vanderbilt.edu
Anand NandkumarIndian School of BusinessVerifisert e-postadresse på isb.edu
Anant MishraAndrew Van de Ven Professorship in Supply Chain and Operations,

Følg

Chirantan Chatterjee

Professor of Development Economics, Innovation & Global Health, University of Sussex Business School

Verifisert e-postadresse på sussex.ac.uk - Startside

Economics of Technological Change/Pharmaceutical Economics


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Does environmental regulation indirectly induce upstream innovation? New evidence from India P Chakraborty, C Chatterjee Research Policy 46 (5), 939-955, 2017	299	2017
Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry L Branstetter, C Chatterjee, MJ Higgins The RAND Journal of Economics 47 (4), 857-890, 2016	149	2016
Gender and its rising role in modern Indian innovation and entrepreneurship C Chatterjee, S Ramu IIMB Management Review 30 (1), 62-72, 2018	71	2018
Ethical issues in health care sector in India C Chatterjee, V Srinivasan IIMB Management Review 25 (1), 49-62, 2013	55	2013
Strong medicine: Patent reform and the emergence of a research-driven pharmaceutical industry in India A Arora, L Branstetter, C Chatterjee NBER Conference on Location of Biopharmaceutical Activity, Boston, MA, 7-8, 2008	54	2008
Starving (or fattening) the golden goose?: generic entry and the incentives for early-stage pharmaceutical innovation L Branstetter, C Chatterjee, MJ Higgins National Bureau of Economic Research, 2014	50	2014
The consumer welfare implications of governmental policies and firm strategy in markets for medicines C Chatterjee, K Kubo, V Pingali Journal of Health Economics 44, 255-273, 2015	42	2015
Women’s disempowerment and preferences for skin lightening products that reinforce colorism: Experimental evidence from India A Adbi, C Chatterjee, C Cortland, Z Kinias, J Singh Psychology of Women Quarterly 45 (2), 178-193, 2021	33*	2021
Price control and access to drugs: The case of india’s malarial market DP Mohapatra, C Chatterjee Working Paper. Cornell University, 2015	33	2015
When the big one came: A natural experiment on demand shock and market structure in India's influenza vaccine markets A Adbi, C Chatterjee, M Drev, A Mishra Production and Operations Management 28 (4), 810-832, 2019	31	2019
Mitigating regulatory impact: the case of partial price controls on metformin in India A Bhaskarabhatla, C Chatterjee, P Anurag, E Pennings Health policy and planning 32 (2), 194-204, 2017	29	2017
Can greater access to education be inequitable? New evidence from India’s Right to Education Act C Chatterjee, EA Hanushek, S Mahendiran National Bureau of Economic Research, 2020	28	2020
Government health insurance and spatial peer effects: New evidence from India C Chatterjee, R Joshi, N Sood, P Boregowda Social Science & Medicine 196, 131-141, 2018	27	2018
Hit where it hurts: cartel policing using targeted sales and supply embargoes A Bhaskarabhatla, C Chatterjee, B Karreman The Journal of Law and Economics 59 (4), 805-846, 2016	24	2016
Intellectual property regimes and wage inequality S Bhattacharya, P Chakraborty, C Chatterjee Journal of Development Economics 154, 102709, 2022	21	2022
Stakeholder orientation and market impact: Evidence from India A Adbi, A Bhaskarabhatla, C Chatterjee Journal of business ethics 161, 479-496, 2020	16	2020
The role of physicians in prescribing irrational fixed-dose combination medicines in India A Bhaskarabhatla, C Chatterjee Social science & medicine 174, 179-187, 2017	15	2017
Data security, data breaches, and compliance C Chatterjee, DD Sokol Cambridge Handbook on Compliance (D. Daniel Sokol & Benjamin van Rooij …, 2019	14	2019
Strong medicine? Patent reform and the transformation of the Indian pharmaceutical industry A Arora, L Branstetter, C Chatterjee, K Saggi mimeo, 2009	14	2009
Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data S Rathi, A Majumdar, C Chatterjee Technological Forecasting and Social Change 198, 122940, 2024	12	2024

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere